Q4 2025 Ultralife Corp Earnings Call Transcript
Key Points
- Ultralife Corp (ULBI) reported a 10.6% year-over-year increase in Q4 revenue, reaching $48.5 million.
- The company achieved a 16.2% year-over-year growth in full-year revenue, totaling $191.2 million.
- The backlog grew to $110 million, a 22.1% increase from the previous quarter, indicating strong future demand.
- The battery and energy product segment saw a 15.1% increase in revenues, driven by significant growth in medical and industrial sectors.
- Ultralife Corp (ULBI) successfully completed the transition of its largest acquisition, Electrochem, integrating it into its systems and operations.
- Ultralife Corp (ULBI) reported a Q4 operating profit loss of $10.6 million due to a one-time non-cash impairment.
- The communication system segment experienced a 35.2% decline in revenues, primarily due to delayed orders from the US government shutdown.
- The company faced a full-year operating profit loss of $5.9 million, resulting in a loss of $0.35 EPS.
- Gross margin for the communication system segment decreased significantly to 19.9% from 31.9% the previous year.
- Ultralife Corp (ULBI) incurred a net loss of $7.4 million or $0.45 per share for Q4, impacted by the intangible asset impairment charge.
Good day and thank you for standing by. Welcome to the Ultralife Corporation fourth-quarter 2025 results call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star, one, one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star, one, one again. Please be advised that today's conference is being recorded. I'd now like to hand the conference over to Jody Burfening. Please go ahead.
Thank you, Liz, and good morning, everyone. And thank you for joining us this morning for Ultralife Corporation's earnings conference call for the fourth quarter of fiscal 2025. With us on today's call are Mike Manna, Ultralife's president and CEO, and Phil Fane, Ultralife's chief financial officer. The earnings press release was issued earlier this morning, and if anyone has not yet received a copy, I invite
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
